Study guide
14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
Key Takeaways Explain This Topic AI
Ultrasound image generation relies on the piezoelectric effect; high-frequency linear probes (10-15 MHz) provide superior spatial resolution for superficial targets (1-4 cm), while low-frequency curvilinear probes (2-5 MHz) maximize tissue penetration for deep structures (10-30 cm).
Tissues exhibit distinct acoustic echogenicities: hyperechoic (bone, fascia, needle, tendon), hypoechoic (muscle, nerve fascicles), and anechoic (fluid, blood, local anesthetic depot); nerves characteristically present a speckled 'honeycomb' pattern.
Color Doppler follows the BART rule (Blue Away, Red Towards the transducer) to differentiate vascular flow; critical imaging artifacts include acoustic shadowing, posterior acoustic enhancement, reverberation, and anisotropy (angle-dependent false hypoechoic nerve disappearance).
Local Anesthetic Systemic Toxicity (LAST) presents with progressive CNS excitation (metallic taste, circumoral numbness, tinnitus, seizures) and depression followed by severe cardiovascular collapse; highly lipophilic agents like bupivacaine can trigger sudden fatal ventricular arrhythmias without preceding CNS prodrome.
The standard ASRA LAST rescue protocol mandates 20% Lipid Emulsion at a 1.5 mL/kg IV bolus over 2-3 minutes followed by a continuous infusion of 0.25-0.5 mL/kg/min (max cumulative dose 10-12 mL/kg in 30 min); ACLS modifications require low-dose epinephrine (<1 mcg/kg boluses) and avoidance of vasopressin, beta-blockers, calcium channel blockers, and lidocaine.
Last updated: August 2026
14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
Ultrasound guidance has transformed regional anesthesia by enabling direct, real-time visualization of target neural structures, adjacent vascular anatomy, needle trajectory, and local anesthetic spread. Concurrently, regional practitioners must maintain crisis readiness for Local Anesthetic Systemic Toxicity (LAST) , an unpredictable, life-threatening emergency requiring prompt administration of 20% Lipid Emulsion and modified resuscitation algorithms.
- 1. Ultrasound Physics: Wave Mechanics & Transducer Selection
- The Piezoelectric Effect
Diagnostic ultrasound operates via the Piezoelectric Effect (discovered by Jacques and Pierre Curie). Synthetic ceramic crystals—primarily Lead Zirconate Titanate (PZT) —within the ultrasound transducer expand and contract when an alternating electrical voltage is applied, generating mechanical acoustic pressure waves. In reverse, reflected sound waves returning from tissue deform the crystals, creating electrical voltages converted by the machine processor into real-time 2D grayscale images. [THE ULTRASOUND WAVE EQUATION]
c = f × λ
- c = Speed of Sound in Human Soft Tissue (Assumed Constant ≈ 1540 m/s)
- f = Frequency (MHz) λ = Wavelength (mm)
- Frequency vs. Spatial Resolution vs. Tissue Penetration
Because the speed of sound in soft tissue is relatively constant ( 1540 m/s 1540 \text{ m/s} 1540 m/s ), frequency and wavelength are inversely related ( λ = c f \lambda = \frac{c}{f} λ = f c ):
High Frequency ( 10 − 15 MHz 10 - 15 \text{ MHz} 10 − 15 MHz ): Short wavelength ( λ ≈ 0.1 − 0.15 mm \lambda \approx 0.1 - 0.15 \text{ mm} λ ≈ 0.1 − 0.15 mm ) yields superior axial resolution (ability to discern two distinct points along the sound beam axis) and lateral resolution (ability to discern two adjacent points across the beam width). However, acoustic attenuation (absorption and scattering) increases exponentially with frequency, limiting useful tissue penetration to 1 − 4 cm 1 - 4 \text{ cm} 1 − 4 cm .
Low Frequency ( 2 − 5 MHz 2 - 5 \text{ MHz} 2 − 5 MHz ): Long wavelength yields lower spatial resolution but experiences minimal tissue attenuation, enabling deep penetration to 10 − 30 cm 10 - 30 \text{ cm} 10 − 30 cm . +-------------------------------------------------------------------------+
- | ULTRASOUND TRANSDUCER COMPARISON |
- +--------------------+-------------------------+--------------------------+
- | Transducer Type | Frequency Range | Clinical Regional Uses |
- +--------------------+-------------------------+--------------------------+
- | **High-Frequency | 10 - 15 MHz | Superficial blocks: |
- | Linear Array** | (High resolution, | • Interscalene |
- | | 1-4 cm penetration) | • Supraclavicular |
- | | | • Axillary / Forearm |
- | | | • Femoral / Saphenous |
- | **Low-Frequency | 2 - 5 MHz | Deep blocks & Obese pts: |
- | Curvilinear** | (Low resolution, | • Lumbar Plexus / Psoas |
- | | 10-30 cm penetration) | • Subgluteal Sciatic |
- | | | • Transmuscular QL |
- | | | • Neuraxial / Epidural |
- +--------------------+-------------------------+--------------------------+
- 2. Acoustic Impedance, Echogenicity & Color Doppler
- Acoustic Impedance ( Z Z Z ) & Reflection
Acoustic impedance is the resistance of a tissue medium to the transmission of sound ( Z = ρ × c Z = \rho \times c Z = ρ × c , where ρ \rho ρ is tissue density and c c c is acoustic velocity). When an ultrasound beam strikes the boundary between two tissues with differing acoustic impedances, a portion of the wave is reflected back to the probe:
Large Δ Z \Delta Z Δ Z (e.g., Soft tissue to Bone or Air): Nearly 100 % 100\% 100% of the sound wave is reflected or absorbed, creating a bright white hyperechoic surface with a total acoustic shadow behind it.
Identical Z Z Z (e.g., Fluids / Blood): Sound transmits completely with zero reflection, creating an echo-free black anechoic image. +-------------------------------------------------------------------------+
- | TISSUE ECHOGENICITY SPECTRUM |
- +------------------+------------------+-----------------------------------+
- | Echogenicity | Visual Grayscale | Anatomical Examples |
- +------------------+------------------+-----------------------------------+
- | **Hyperechoic** | Bright White | Bone cortex, fascial planes, |
- | | | needle shaft/tip, tendon, epineur.|
- | **Hypoechoic** | Dark Gray | Muscle fibers, nerve fascicles, |
- | | | lymph nodes, cartilage |
- | **Anechoic** | Pitch Black | Blood vessels, local anesthetic, |
- | | | seromas, fluid cysts, bladder |
- +------------------+------------------+-----------------------------------+
- Sonographic Architecture of Peripheral Nerves
In cross-section, peripheral nerves display a characteristic "honeycomb" (or "salt-and-pepper") appearance :
Hypoechoic Dots: Multiple individual nerve fascicles carrying axons.
Hyperechoic Surrounding Ring: Dense fibroconnective tissue sheaths ( perineurium and outer epineurium ).
Color Doppler & The BART Rule
Color Doppler detects frequency shifts in reflected sound waves from moving erythrocytes to visualize blood flow:
BART Rule: B lue A way, R ed T owards the transducer.
Clinical Utility: Differentiates vascular structures from cystic or nerve structures. Color denotes direction of flow relative to the probe face , not oxygenated vs. deoxygenated blood.
Vessel Differentiation: Arteries are pulsatile, thick-walled, and resist light compression; veins are thin-walled, non-pulsatile, and easily collapsed with gentle probe pressure.
3. Needle Visualization: In-Plane (IP) vs. Out-of-Plane (OOP) +-------------------------------------------------------------------------+
- | IN-PLANE vs OUT-OF-PLANE NEEDLE GUIDANCE |
- +--------------------+------------------------+---------------------------+
- | Feature | In-Plane (IP) | Out-of-Plane (OOP) |
- +--------------------+------------------------+---------------------------+
- | **Needle-to-Probe | Parallel (Long axis) | Perpendicular (Short axis)|
- | Orientation** | | |
- | **Visualization** | Entire needle shaft | Single bright hyperechoic |
- | | AND tip visible | dot (cross-section) |
- | **Safety Profile** | **Highest Safety:** | **High Risk:** Needle |
- | | Continuous tip tracking| shaft shadow mistaken for |
- | | prevents deep injury | true unseen tip |
- | **Optimal Use** | Peripheral nerve blocks| Vascular cannulation |
- | | (Interscalene, Supra) | (IJV, Radial Artery), TAP |
+--------------------+------------------------+---------------------------+ [IN-PLANE vs OUT-OF-PLANE GEOMETRY]
IN-PLANE (Long-Axis) OUT-OF-PLANE (Short-Axis)
- [ PROBE FACE ] [ PROBE FACE ]
- /==============\ /==============\
- | || || | | (•) | (Single dot cross-sec)
- | || || | | |
- \==============/ \==============/
- \ |
- \-- [Needle fully in beam] v [Needle passes
- perpendicularly]
- Hydro-Localization / Hydro-Dissection
When needle tip visibility is ambiguous, injecting 0.5 − 1.0 mL 0.5 - 1.0 \text{ mL} 0.5 − 1.0 mL of normal saline or D5W expands the surrounding tissue plane with an anechoic fluid pocket. This dynamically confirms needle tip location and separates delicate neural structures from fascial boundaries before depositing local anesthetic.
4. Key Ultrasound Artifacts in Regional Anesthesia +-------------------------------------------------------------------------+
- | COMMON ULTRASOUND ARTIFACTS |
- +-----------------------+-------------------------------------------------+
- | Artifact Name | Physical Mechanism & Regional Impact |
- +-----------------------+-------------------------------------------------+
- | **Acoustic | Bone or dense fascia reflects/absorbs almost |
- | Shadowing** | all sound waves; dark signal-void shadow behind |
- | | (e.g., acoustic shadow beneath first rib) |
- | **Posterior Acoustic | Sound traverses anechoic fluid (vessel/LA pool) |
- | Enhancement** | with minimal attenuation; tissues directly deep |
- | | appear artificially bright (hyperechoic) |
- | **Reverberation** | Sound bounces back and forth between two strong |
- | | parallel reflectors (metal needle and probe); |
- | | multiple equidistant parallel 'ghost' lines |
- | **Anisotropy** | Incident sound beam deviates from 90° |
- | | perpendicular; reflected waves miss probe; nerve|
- | | falsely turns dark/hypoechoic or disappears! |
- +-----------------------+-------------------------------------------------+
- The Anisotropy Phenomenon
Mechanism: Peripheral nerves and tendons are specular reflectors . When the ultrasound beam strikes the nerve bundle at a precise 90 ∘ 90^\circ 9 0 ∘ perpendicular angle of insonation, maximum sound reflects back to the transducer, displaying a bright hyperechoic honeycomb pattern.
The Pitfall: If the probe is tilted even 5 − 10 ∘ 5 - 10^\circ 5 − 1 0 ∘ away from perpendicular, the reflected waves reflect away from the transducer. The nerve falsely loses its echogenicity and appears dark (hypoechoic) or completely blends into surrounding muscle.
Correction: Perform "heel-toe" rocking or probe tilting to align the incident beam perpendicular ( 90 ∘ 90^\circ 9 0 ∘ ) to the nerve axis.
5. Local Anesthetic Systemic Toxicity (LAST): Pathophysiology & Progression
LAST is a life-threatening systemic crisis triggered by inadvertent direct intravascular injection or rapid systemic vascular absorption of local anesthetic.
Cellular Pathophysiology
Myocardial Na⁺ Channel Blockade: Local anesthetics bind to voltage-gated cardiac fast N a + Na^+ N a + channels ( I N a I_{Na} I N a ) in their open/inactivated states, depressing Phase 0 cardiac depolarization. Highly lipophilic amino-amides—especially Bupivacaine —exhibit "fast-in, slow-out" receptor binding kinetics; they bind avidly during systole and dissociate extremely slowly during diastole, causing profound conduction delay (PR prolongation, bundle branch block, QRS widening) and re-entrant ventricular arrhythmias.
Mitochondrial Inhibition: Bupivacaine uncouples oxidative phosphorylation and inhibits carnitine-acylcarnitine translocase , halting fatty acid transport into myocardial mitochondria and causing catastrophic cellular ATP depletion.
Hierarchy of Systemic Absorption by Injection Site
Rate of systemic vascular absorption depends directly on the vascularity and capillary density of the anatomic site: Intercostal > Caudal > Epidural > Brachial Plexus > Femoral / Sciatic > Subcutaneous \text{Intercostal} > \text{Caudal} > \text{Epidural} > \text{Brachial Plexus} > \text{Femoral / Sciatic} > \text{Subcutaneous} Intercostal > Caudal > Epidural > Brachial Plexus > Femoral / Sciatic > Subcutaneous
(Mnemonic: ICEBS — I C an't E valuate B locks S afely) [LAST CLINICAL PROGRESSION TIMELINE]
- CNS EXCITATION (Initial Signs) --> CNS DEPRESSION & SEIZURES
- Circumoral numbness & tingling • Muscle twitching & fasciculations
- Metallic taste in mouth • Grand Mal Tonic-Clonic Seizures
- Tinnitus & auditory ringing • Global CNS Depression, Coma, Apnea
- Lightheadedness, slurred speech |
- v
- CARDIOVASCULAR COLLAPSE (CVS) <-- CARDIOVASCULAR CONDUCTION BLOCKS
- Severe myocardial depression • PR prolongation, QRS widening
- Refractory Bradycardia / Asystole • Ventricular Tachycardia (VT) / VF
- Extreme Hypotension & Shock • Torsades de Pointes / Arrest
NCE Board Warning — Bupivacaine Cardiotoxicity: Bupivacaine has a narrow Cardiotoxic-to-Therapeutic (C:T) ratio ( C : T ≈ 2.0 C:T \approx 2.0 C : T ≈ 2.0 vs Lidocaine C : T ≈ 7.0 C:T \approx 7.0 C : T ≈ 7.0 ). In rapid intravascular bupivacaine administration, severe cardiovascular collapse, malignant ventricular arrhythmias, or asystole can occur precipitously WITHOUT ANY PRECEDING CNS WARNING SYMPTOMS!
6. ASRA LAST Treatment & 20% Lipid Emulsion Resuscitation Protocol +-------------------------------------------------------------------------+
- | ASRA LAST CRISIS CHECKLIST & LIPID RESUSCITATION |
- +-------------------------------------------------------------------------+
- | |
- | STEP 1: Immediate Cessation & Airway Management |
- | • HALT local anesthetic injection immediately |
- | • Call for Help, Code Cart, and LAST Rescue Kit (20% Lipid Emulsion) |
- | • Ventilate with 100% FiO₂; hyperventilate slightly |
- | • PREVENT ACIDOSIS & HYPERCARBIA (acidosis increases free unbound LA; |
- | hypercarbia increases cerebral blood flow and CNS delivery) |
- | |
- | STEP 2: Seizure Suppression |
- | • Administer Benzodiazepines first-line: Midazolam 1 - 2 mg IV |
- | • AVOID large doses of Propofol (worsens myocardial depression) |
- | |
- | STEP 3: 20% LIPID EMULSION THERAPY (INTRALIPID) |
- | • INITIAL BOLUS: 20% Lipid Emulsion 1.5 mL/kg IV over 2 - 3 minutes |
- | (~100 - 120 mL in a 70 - 80 kg adult) |
- | • CONTINUOUS INFUSION: 0.25 to 0.5 mL/kg/min |
- | (~20 - 30 mL/min) |
- | • REPEAT BOLUS: If hemodynamically unstable, repeat 1.5 mL/kg bolus |
- | once or twice every 3 - 5 min; increase infusion to 0.5 mL/kg/min |
- | • MAXIMUM CUMULATIVE DOSE: 10 to 12 mL/kg over the first 30 minutes |
- | • Continue infusion for ≥ 15 minutes after hemodynamic stability |
- | |
- | STEP 4: MODIFIED ACLS RESUSCITATION RULES |
- | • REDUCE Epinephrine: Small boluses < 1 mcg/kg (10 - 100 mcg IV) |
- | (Standard 1 mg Epi impairs lipid rescue and worsens arrhythmias) |
- | • AVOID VASOPRESSIN (induces intense pulmonary/coronary constriction) |
- | • AVOID Calcium Channel Blockers and Beta-Blockers |
- | • AVOID Local Anesthetic Antiarrhythmics (Lidocaine, Procainamide) |
- | • Antiarrhythmic of Choice: AMIODARONE for ventricular arrhythmias |
- | • Alert ECMO / Cardiopulmonary Bypass team for refractory arrest |
- +-------------------------------------------------------------------------+
- Mechanism of Action of 20% Lipid Emulsion ("Lipid Sink" & Metabolic Pull)
Lipid Sink (Scavenging): Lipid droplets create a massive intravascular hydrophobic lipid compartment that partitions and extracts lipophilic local anesthetic molecules from highly perfused target tissues (brain and heart), driving concentration gradients away from myocardium.
Metabolic & Inotropic Effect: Lipid emulsion supplies abundant long-chain fatty acid substrates directly to cardiac mitochondria, overcoming bupivacaine's metabolic blockade of carnitine-acylcarnitine translocase and restoring cellular ATP generation.